BIOLASE Other Stockholder Equity vs Total Liab Analysis
BIOL Stock | USD 0.16 0.01 6.67% |
BIOLASE financial indicator trend analysis is way more than just evaluating BIOLASE prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BIOLASE is a good investment. Please check the relationship between BIOLASE Other Stockholder Equity and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.
Other Stockholder Equity vs Total Liab
Other Stockholder Equity vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BIOLASE Other Stockholder Equity account and Total Liab. At this time, the significance of the direction appears to have strong relationship.
The correlation between BIOLASE's Other Stockholder Equity and Total Liab is 0.73. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Liab in the same time period over historical financial statements of BIOLASE, assuming nothing else is changed. The correlation between historical values of BIOLASE's Other Stockholder Equity and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of BIOLASE are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Other Stockholder Equity i.e., BIOLASE's Other Stockholder Equity and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Other Stockholder Equity
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from BIOLASE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BIOLASE current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.At this time, BIOLASE's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 138.6 K this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.20.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 16.5M | 15.9M | 16.7M | 17.3M | Total Revenue | 39.2M | 48.5M | 49.2M | 38.5M |
BIOLASE fundamental ratios Correlations
Click cells to compare fundamentals
BIOLASE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BIOLASE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.8M | 41.0M | 55.3M | 38.2M | 35.1M | 31.3M | |
Short Long Term Debt Total | 13.5M | 18.0M | 15.1M | 15.1M | 17.9M | 18.8M | |
Other Current Liab | 4.7M | 6.4M | 7.9M | 9.2M | 8.0M | 8.4M | |
Total Current Liabilities | 25.8M | 11.2M | 13.8M | 17.8M | 19.7M | 14.3M | |
Total Stockholder Equity | 377K | 10.0M | 25.2M | 4.9M | (247K) | (234.7K) | |
Property Plant And Equipment Net | 1.5M | 2.8M | 2.8M | 6.0M | 7.0M | 7.4M | |
Net Debt | 7.7M | 396K | (14.9M) | 10.9M | 11.3M | 11.9M | |
Retained Earnings | (234.5M) | (251.4M) | (267.5M) | (296.2M) | (316.8M) | (301.0M) | |
Accounts Payable | 5.3M | 2.7M | 3.3M | 5.8M | 6.1M | 4.9M | |
Cash | 5.8M | 17.6M | 30.0M | 4.2M | 6.6M | 7.9M | |
Non Current Assets Total | 4.8M | 5.9M | 5.9M | 9.2M | 10.2M | 5.7M | |
Non Currrent Assets Other | 433K | 231K | 220K | 255K | 268K | 277.2K | |
Cash And Short Term Investments | 5.8M | 17.6M | 30.0M | 4.2M | 6.6M | 9.6M | |
Net Receivables | 8.8M | 3.1M | 4.2M | 5.8M | 5.5M | 6.3M | |
Common Stock Shares Outstanding | 9.3K | 24.5K | 59.1K | 69.3K | 1.3M | 1.3M | |
Liabilities And Stockholders Equity | 31.8M | 41.0M | 55.3M | 38.2M | 35.1M | 31.3M | |
Non Current Liabilities Total | 5.7M | 19.8M | 16.2M | 15.5M | 15.7M | 16.5M | |
Inventory | 11.0M | 11.2M | 12.9M | 15.9M | 11.4M | 8.1M | |
Other Current Assets | 1.2M | 3.0M | 2.0M | 3.1M | 1.4M | 1.5M | |
Other Stockholder Equity | 231.6M | 261.6M | 293.2M | 301.8M | 314.9M | 330.6M | |
Total Liab | 31.5M | 31.0M | 30.1M | 33.3M | 35.3M | 18.3M | |
Property Plant And Equipment Gross | 1.5M | 2.8M | 2.8M | 6.0M | 18.4M | 19.3M | |
Total Current Assets | 27.0M | 35.1M | 49.4M | 29.0M | 24.9M | 25.5M | |
Accumulated Other Comprehensive Income | (701K) | (385K) | (623K) | (733K) | (553K) | (580.7K) | |
Short Term Debt | 13.5M | 305K | 405K | 700K | 3.2M | 2.9M | |
Common Stock Total Equity | 102K | 21K | 31K | 98K | 112.7K | 118.3K | |
Common Stock | 31K | 98K | 154K | 8K | 3K | 2.9K | |
Other Assets | 433K | 2.2M | 220K | 255K | 229.5K | 218.0K | |
Property Plant Equipment | 1.2M | 2.8M | 2.8M | 6.0M | 7.0M | 7.3M | |
Other Liab | 1.7M | 1.8M | 1.2M | 1.1M | 1.0M | 1.1M | |
Current Deferred Revenue | 2.2M | 1.9M | 2.3M | 2.1M | 2.5M | 2.3M | |
Net Tangible Assets | 8.2M | 1.4M | 7.0M | 22.2M | 20.0M | 12.3M | |
Retained Earnings Total Equity | (195.2M) | (216.7M) | (234.5M) | (251.4M) | (226.2M) | (237.6M) | |
Capital Surpluse | 224.9M | 228.4M | 235.6M | 261.6M | 300.8M | 214.9M | |
Deferred Long Term Liab | 115K | 77K | 436K | 374K | 336.6K | 368.5K | |
Non Current Liabilities Other | 1.3M | 1.1M | 330K | 362K | 79K | 75.1K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as BIOLASE using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for BIOLASE Stock analysis
When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.97) | Revenue Per Share 8.632 | Quarterly Revenue Growth (0.03) | Return On Assets (0.26) | Return On Equity (5.05) |
The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.